Академический Документы
Профессиональный Документы
Культура Документы
B.
C.
D.
REFERENCIAS
1. Michael Benatar, M.B.CH.B., M.S., D.Phil; Pearls: myasthenia; Seminars in
neurology, volume 30 (1) 2010; 35-37.
2. Brian A. Van Adel, Md, Phd, And Mark A. Tarnopolsky, Md, Phd, Frcpc;
Metabolic Myopathies: Update 2009; Journal Of Clinical Neuromuscular
Disease;Volume (3), March 2009; 97-121.
3. Janet Schmiedel Sandra Jackson Jochen Schfer Heinz Reichmann;
Mitochondrial Cytopathies; Journal of Neurology Volume 250, 2003; 267277.
g
4. Kathleen Patterson; Mitochondrial Muscle Pathology; Pediatric and
Developmental Pathology, volume (7), 2004; 629632.
5. T. D. Jeppesena, M. Dunb, M. Schwartzb, T. Kraga, J. Rafiqa, F. Wibrandb
and J. Vissinga; Short- and long-term effects of endurance training in patients
with mitochondrial myopathy; European Journal of Neurology, Volume 16,
2009; 13361339.
6. Ralph W. Kuncl; Agents and mechanisms of toxic myopathy; Current Opinion
in Neurology 2009, 22:506515
7. A. Craig Chinault, PhD, Chad A. Shaw, PhD, Ellen K. Brundage, BA, Lin-Ya
Tang, MS, and Lee-Jun C. Wong, PhD; Application of dual-genome
oligonucleotide array-based comparative genomic hybridization to the
molecular diagnosis of mitochondrial DNA deletion and depletion syndromes;
Genetics IN Medicine; Volume 11(7), July 2009; 518-526.